About the Authors

Mayukh Das

Affiliations Department of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, United States of America, Center for Phage Technology, Texas A&M University, College Station, Texas, United States of America

Tushar Suvra Bhowmick

Affiliations Department of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, United States of America, Center for Phage Technology, Texas A&M University, College Station, Texas, United States of America

Stephen J. Ahern

Affiliations Department of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, United States of America, Center for Phage Technology, Texas A&M University, College Station, Texas, United States of America

Ry Young

Affiliations Center for Phage Technology, Texas A&M University, College Station, Texas, United States of America, Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas, United States of America

Carlos F. Gonzalez

cf-gonzalez@tamu.edu

Affiliations Department of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas, United States of America, Center for Phage Technology, Texas A&M University, College Station, Texas, United States of America

Competing Interests

The authors have the following interests: This project was funded by a grant to the Center for Phage Technology and Texas A&M AgriLife Research from Otsuka Pharmaceutical Co., Ltd. The following provisional patent was filed in October of 2013 (US Application: Application Name "Method for treatment and control of plant disease", Application Number 14/057,851; International Application: Application Name "Methods and Compositions for Treatment and Control of Plant Disease", Application Number PCT/US2013/065710; Argentina Application: Application Name "Method for treatment and control of plant disease", Application Number P130103786). Texas A&M AgriLife Research in cooperation with the Texas A&M System Office of Technology Commercialization signed a licensing agreement with Otsuka Pharmaceutical Co., Ltd. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: CFG RY MD TSB. Performed the experiments: MD TSB. Analyzed the data: MD TSB CFG. Contributed reagents/materials/analysis tools: CFG. Wrote the paper: MD TSB CFG. Manuscript editing with extensive critical input: SJA RY.